- The US Food and Drug Administration is set to consider easing restrictions on over half a dozen unapproved peptide injections, which are popular among wellness influencers and celebrities.
- This review, scheduled for July, follows pledges from Health Secretary Robert F. Kennedy Jr., who has publicly supported peptides and used them himself, to loosen regulations.
- Many of these peptides, often marketed for muscle building, injury healing, or anti-aging, lack significant research and have not been reviewed for safety by the FDA.
- The agency restricted the substances under former President Joe Biden, citing “significant safety risks” and a lack of extensive human testing, a decision now being re-evaluated.
- The FDA said in a federal notice Wednesday that it will ask a panel of outside pharmacy advisers to review seven peptides, specifically whether they should be moved from a restrictive category reserved for risky, customized drugs.
IN FULL
